Ballicules.com
Withdrawn from the market (business decision)

Ethchlorvynol

PLACIDYL

Ethchlorvynol ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Ethchlorvynol ballicule

What it isTertiary acetylenic alcohol sedative-hypnotic; withdrawn.

Why this oneIt was a widely used hypnotic before the benzodiazepines.

What limits itNarrow margin, dependence and a difficult overdose. US marketing discontinued in 1999.

Ethchlorvynol molecular structure (skeletal formula)
Molecular structure: Ethchlorvynol

Ethchlorvynol prescription history

Animated chart of estimated U.S. prescriptions per year, Sleep meds (1869–2026). Ethchlorvynol enters in 1955 (estimated).

FDA-approved for

NO BOXED WARNINGS

Principal riskWithdrawn; narrow margin and dependence

Classes and tags

Clinical profile

Therapeutic safety burden3 / 4
Sedation liability3 / 4
Direct muscarinic antagonism0 / 4

Defining liabilityDependence and potentially prolonged CNS depression

Open Ethchlorvynol in the interactive console ↗

Self-check